Bill Text: NY A08285 | 2013-2014 | General Assembly | Introduced


Bill Title: Establishes an emergency opioid overdose prevention pilot program whereby police agencies and certain public high schools could administer Naloxone, an opioid inverse agonist, to persons who have overdosed on an opioid; provides for the admininstration of Naloxone pursuant to the opioid overdose prevention program.

Spectrum: Slight Partisan Bill (Democrat 6-2)

Status: (Introduced - Dead) 2014-01-08 - referred to health [A08285 Detail]

Download: New_York-2013-A08285-Introduced.html
                           S T A T E   O F   N E W   Y O R K
       ________________________________________________________________________
                                         8285
                              2013-2014 Regular Sessions
                                 I N  A S S E M B L Y
                                   November 20, 2013
                                      ___________
       Introduced by M. of A. LENTOL -- read once and referred to the Committee
         on Health
       AN  ACT  to  amend the public health law, in relation to establishing an
         emergency opioid overdose prevention pilot  program  and  the  use  of
         opioid inverse agonists in opioid overdose prevention
         THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
       BLY, DO ENACT AS FOLLOWS:
    1    Section 1. Section 3309 of the public health law, as added by  chapter
    2  413 of the laws of 2005, is amended to read as follows:
    3    S  3309. Opioid overdose prevention. 1. The commissioner is authorized
    4  to establish standards for approval of any  opioid  overdose  prevention
    5  program  which may include, but not be limited to, standards for program
    6  directors, appropriate clinical oversight, training, record keeping  and
    7  reporting.
    8    2.  THE  COMMISSIONER  SHALL  ESTABLISH  AN  EMERGENCY OPIOID OVERDOSE
    9  PREVENTION PILOT PROGRAM. SUCH PROGRAM SHALL:
   10    (A) MAKE NALOXONE AVAILABLE TO  ALL  LAW  ENFORCEMENT  AGENCIES,  UPON
   11  REQUEST;  PROVIDED  THAT  THE POLICE OFFICERS OF SUCH AGENCY CAN CERTIFY
   12  THAT THEY HAVE RECEIVED THE TRAINING ESTABLISHED PURSUANT  TO  PARAGRAPH
   13  (C) OF THIS SUBDIVISION;
   14    (B)  PROVIDE  NALOXONE  TO  NOT  MORE  THAN THIRTY PUBLIC HIGH SCHOOLS
   15  THROUGHOUT THE STATE. THE COMMISSIONER SHALL SELECT NOT  LESS  THAN  TWO
   16  PUBLIC  HIGH  SCHOOLS IN EACH OF THE FOLLOWING REGIONS TO PARTICIPATE IN
   17  THE PROGRAM ESTABLISHED PURSUANT TO THIS SUBDIVISION: LONG  ISLAND,  THE
   18  CITY  OF  NEW  YORK, THE CAPITAL DISTRICT, THE HUDSON VALLEY, THE MOHAWK
   19  VALLEY, THE NORTH COUNTRY, CENTRAL NEW  YORK,  THE  SOUTHERN  TIER,  THE
   20  FINGER  LAKES  AND  WESTERN  NEW YORK. THE SCHOOL NURSE AND AT LEAST ONE
   21  OTHER STAFF MEMBER OF EACH PARTICIPATING HIGH SCHOOL SHALL  RECEIVE  THE
   22  TRAINING ESTABLISHED PURSUANT TO PARAGRAPH (C) OF THIS SUBDIVISION; AND
   23    (C)  PROVIDE  TRAINING,  OR  WORK  WITH LOCAL ORGANIZATIONS TO PROVIDE
   24  TRAINING, ON THE PROPER USE AND ADMINISTRATION OF NALOXONE.
        EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                             [ ] is old law to be omitted.
                                                                  LBD10215-02-3
       A. 8285                             2
    1    3. Notwithstanding any inconsistent provisions of  section  sixty-five
    2  hundred  twelve  of  the  education  law or any other law, the purchase,
    3  acquisition, possession or use of an  opioid  antagonist  OR  AN  OPIOID
    4  INVERSE AGONIST pursuant to this section shall not constitute the unlaw-
    5  ful practice of a profession or other violation under title eight of the
    6  education law or this article.
    7    [3.]  4.  Use  of  an  opioid  antagonist OR AN OPIOID INVERSE AGONIST
    8  pursuant to this section shall be  considered  first  aid  or  emergency
    9  treatment for the purpose of any statute relating to liability.
   10    [4.]  5.  The  commissioner shall publish findings on statewide opioid
   11  overdose data [that reviews], INCLUDING:
   12    (A) USE OF NALOXONE UNDER THE PILOT PROGRAM  ESTABLISHED  PURSUANT  TO
   13  SUBDIVISION TWO OF THIS SECTION;
   14    (B) overdose death rates;
   15    (C)  AGE, GENDER, ETHNICITY AND GEOGRAPHIC LOCATION OF OPIOID OVERDOSE
   16  DEATHS;
   17    (D) EMERGENCY ROOM UTILIZATION FOR TREATMENT OF OPIOID OVERDOSES;
   18    (E) UTILIZATION OF PRE-HOSPITAL SERVICES FOR OPIOID OVERDOSES; and
   19    (F) ANY other information NECESSARY to ascertain THE SUCCESS OF NALOX-
   20  ONE USE AND changes in the cause and rates of  fatal  opioid  overdoses.
   21  The [report] FINDINGS, WHICH may be part of AN existing [state mortality
   22  reports  issued by the department, and] REPORT, shall be submitted annu-
   23  ally [for three years and as deemed necessary by the commissioner there-
   24  after,] to [the governor,] the temporary president of the senate  [and],
   25  THE CHAIR OF THE SENATE STANDING COMMITTEE ON HEALTH, the speaker of the
   26  assembly  AND  THE  CHAIR OF THE ASSEMBLY HEALTH COMMITTEE.  [The report
   27  shall include, at a minimum, the following information:
   28    (a) information on opioid  overdose  deaths,  including  age,  gender,
   29  ethnicity, and geographic location;
   30    (b)  data  on  emergency  room utilization for the treatment of opioid
   31  overdose;
   32    (c) data on utilization of pre-hospital services;
   33    (d) suggested improvements in data collection.]
   34    S 2. This act shall take effect immediately.
feedback